DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost

By Davis H.L.   Mancini M.   Michel M.-L.   Whalen R.G.  

Vaccine, Vol. 14, Iss. 9, 1996-06 ,pp. : 910-915

Elsevier

Access to resources Recommend Favorite

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein

By Yamada T.   Iwabuki H.   Kanno T.   Tanaka H.   Kawai T.   Fukuda H.   Kondo A.   Seno M.   Tanizawa K.   Kuroda S.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3154-3163

Elsevier

Access to resources Recommend Favorite

T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice

By Jones C.D.   Page M.   Bacon A.   Cahill E.   Bentley M.   Chatfield S.N.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2528-2537

Elsevier

Access to resources Recommend Favorite

Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection

By Chen X.   Li M.   Le X.   Ma W.   Zhou B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 439-446

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

By Leroux-Roels G.   Desombere I.   De Tollenaere G.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1724-1731

Elsevier

Access to resources Recommend Favorite